keep away from direct sunlight | Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Belinostat (PXD101) 是一种异羟肟酸型组蛋白脱乙酰酶抑制剂,具有抗肿瘤活性,在 HeLa 细胞提取物中的IC50为 27 nM。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
1 mg | ¥ 196 | 现货 | ||
5 mg | ¥ 393 | 现货 | ||
10 mg | ¥ 635 | 现货 | ||
25 mg | ¥ 987 | 现货 | ||
50 mg | ¥ 1,490 | 现货 | ||
100 mg | ¥ 2,180 | 现货 | ||
200 mg | ¥ 3,480 | 现货 | ||
500 mg | ¥ 5,560 | 现货 | ||
1 mL * 10 mM (in DMSO) | ¥ 150 | 现货 |
产品描述 | Belinostat (PXD101) is an inhibitor of hydroxamic acid-type histone deacetylase (HDAC, IC50 of 27 nM in HeLa cell extracts),and with antineoplastic activity. |
靶点活性 | HDAC6:82 nM , HDAC:27 nM (Hela cell) |
体外活性 | PXD101 is a novel hydroxamate-type inhibitor of histone deacetylase activity that inhibits histone deacetylase activity in HeLa cell extracts with an IC(50) of 27 nM and induces a concentration-dependent (0.2-5 micro M) increase in acetylation of histone H4 in tumor cell lines.?PXD101 is cytotoxic in vitro in a number of tumor cell lines with IC(50)s in the range 0.2-3.4 micro M as determined by a clonogenic assay and induces apoptosis. |
体内活性 | Treatment of nude mice bearing human ovarian and colon tumor xenografts with PXD101 (10-40 mg/kg/day i.p.) daily for 7 days causes a significant dose-dependent growth delay with no obvious signs of toxicity to the mice.?Growth delay is also observed for xenografts of cisplatin-resistant ovarian tumor cells.?A marked increase in acetylation of H4 is detected in blood and tumor of mice 3 h after treatment with PXD101.?The inhibition of growth of human tumor xenografts in mice, with no apparent toxicity, suggests that PXD101 has potential as a novel antitumor agent. |
别名 | PX105684, PXD101, 贝利司他, PXD-101 |
分子量 | 318.35 |
分子式 | C15H14N2O4S |
CAS No. | 866323-14-0 |
keep away from direct sunlight | Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 135 mg/mL (424.068 mM)
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
DMSO | 1 mM | 3.1412 mL | 15.706 mL | 31.412 mL | 78.5299 mL |
5 mM | 0.6282 mL | 3.1412 mL | 6.2824 mL | 15.706 mL | |
10 mM | 0.3141 mL | 1.5706 mL | 3.1412 mL | 7.853 mL | |
20 mM | 0.1571 mL | 0.7853 mL | 1.5706 mL | 3.9265 mL | |
50 mM | 0.0628 mL | 0.3141 mL | 0.6282 mL | 1.5706 mL | |
100 mM | 0.0314 mL | 0.1571 mL | 0.3141 mL | 0.7853 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
Belinostat 866323-14-0 Autophagy Chromatin/Epigenetic DNA Damage/DNA Repair HDAC Histone deacetylases Inhibitor PX105684 PX-105684 PXD101 PXD 101 inhibit 贝利司他 PX 105684 PXD-101 inhibitor